Givaudan Past Earnings Performance
Past criteria checks 3/6
Givaudan has been growing earnings at an average annual rate of 8.3%, while the Chemicals industry saw earnings declining at 2.8% annually. Revenues have been growing at an average rate of 3.2% per year. Givaudan's return on equity is 23.4%, and it has net margins of 14.3%.
Key information
8.34%
Earnings growth rate
8.32%
EPS growth rate
| Chemicals Industry Growth | 5.98% |
| Revenue growth rate | 3.18% |
| Return on equity | 23.45% |
| Net Margin | 14.33% |
| Next Earnings Update | 23 Jul 2026 |
Recent past performance updates
Recent updates
GIVN: Fair Outlook Will Reflect Split Bank Views And AI Beauty Push
Givaudan's analyst price target has been reset from CHF 2,875 to CHF 2,800, as analysts weigh recent upgrades alongside a mix of smaller target increases and larger reductions from major banks. Analyst Commentary Recent Street research around Givaudan has been mixed, with some upgrades and modest price target increases sitting alongside a series of larger cuts and downgrades from major banks.GIVN: Fair Outlook Balances Dividend Stability With Mixed Bank Rating Revisions
Givaudan's analyst price target is held at CHF 2,875, with minor adjustments to the discount rate, revenue growth, and profit margin assumptions reflecting a mixed set of recent analyst actions, including modest price target changes and rating shifts across major banks. Analyst Commentary Recent research on Givaudan shows a split view, with some large banks turning more constructive while several bearish analysts continue to flag risks around valuation and execution.
GIVN: Cautious Downgrades Will Support Future Margin Resilience And Re Rating Potential
Givaudan's analyst price target has been reduced from about CHF 3,748 to roughly CHF 3,447. This reflects analysts' recent rounds of target cuts and downgrades following more cautious assumptions on growth, margins and future P/E multiples.GIVN: Fair Stance Will Balance Dividend Appeal And Cautious Bank Revisions
Givaudan's analyst price target is trimmed to CHF 2,875 from CHF 2,900 as analysts factor in more cautious assumptions about revenue growth, slightly firmer profit margins and updated P/E expectations following a series of recent target cuts across the Street. Analyst Commentary Recent Street research around Givaudan has leaned more cautious, with several bearish analysts trimming price targets and reassessing the risk and reward trade off.GIVN: Fair Stance Will Weigh Dividend Support Against Cautious Bank Views
Analysts have trimmed their Givaudan price targets by up to several hundred CHF, reflecting slightly lower assumptions for revenue growth and profit margins while keeping fair value broadly anchored around CHF 2,900 as they adjust discount rate and P/E inputs. Analyst Commentary Recent Street research on Givaudan skews cautious, with several bearish analysts cutting price targets by CHF 150 to CHF 400 as they reset their expectations around revenue growth, margins, and the appropriate P/E to pay for the shares.GIVN: Fair Stance Will Reflect Cautious Bank Views On Future Earnings
Analysts have lowered their price target on Givaudan to CHF 2,900 from CHF 3,100, reflecting updated assumptions around slightly higher discount rates, more cautious revenue growth, a marginally lower profit margin outlook, and a modestly reduced future P/E multiple in light of recent target cuts and a downgrade from several major banks. Analyst Commentary Recent Street research on Givaudan has tilted more cautious, with a cluster of price target cuts and at least one fresh downgrade from a major global bank.GIVN: Chinese Pricing Pressure Will Support Future Margin Resilience And Re Rating Potential
Analysts have reduced their fair value estimate for Givaudan from CHF 3,946.93 to CHF 3,747.83. This change reflects a series of lower Street price targets and incorporates assumptions for steady revenue growth, slightly higher profit margins and a lower future P/E multiple.Givaudan (VTX:GIVN) Is Increasing Its Dividend To CHF72.00
Feb 01
GIVN: Recalibrated Valuation Support Will Sustain Outperformance Versus Chinese Pricing Pressure
Our updated analyst price target for Givaudan shifts to CHF 3,947 from CHF 4,021, as analysts factor in only modest adjustments to growth, margins, and future P/E assumptions, while recent upgrades highlight improved relative positioning and valuation support. Analyst Commentary Recent research suggests sentiment around Givaudan is improving, with upgrades linked mainly to valuation support and relative positioning versus peers, rather than big changes to fundamental assumptions.GIVN: Fair Stance Will Reflect Resilience To Chinese Pricing Pressure
Analysts now frame their Givaudan price target at CHF 3,100, with updated assumptions reflecting a 3.9% revenue growth outlook, a 15.4% profit margin profile, and a forward P/E of about 24.5x. This view is supported by recent upgrades that highlight valuation and relative resilience versus Chinese competition and pricing pressure.GIVN Will Face Mixed Rating Shifts Amid Intensifying Competition And Pricing Pressures
Analysts have trimmed their price target for Givaudan by CHF 100 to CHF 3,100. This reflects slightly softer assumptions for long term revenue growth and margins, even as they continue to view the company as relatively well positioned against intensifying competition and pricing pressures.GIVN: Peer-Leading Organic Sales Will Sustain Outperformance Versus Chinese Competition
Analysts have nudged their fair value estimate for Givaudan slightly higher, from approximately CHF 3,995 to CHF 4,021. This reflects modest upgrades to long term revenue growth and profit margin assumptions as they emphasize the company’s relative resilience to Chinese competition and its peer leading organic sales growth.Subdued Growth No Barrier To Givaudan SA's (VTX:GIVN) Price
Nov 28GIVN: Peer-Leading Organic Sales Growth Will Drive Outperformance Amid Competitive Pressures
Analysts have slightly reduced their fair value estimate for Givaudan, lowering the price target from approximately CHF 4,005 to CHF 3,995. This adjustment reflects recent cautious sentiment amid ongoing pricing and competitive pressures in the sector.Returns At Givaudan (VTX:GIVN) Are On The Way Up
Nov 12GIVN: Peer-Leading Organic Sales Growth Will Support Share Price Recovery
Analysts have decreased their price targets for Givaudan, citing persistent challenges in the consumer chemicals sector and a cautious outlook on peer-relative performance. The targets now range from CHF 3,300 to CHF 3,725, down from previous estimates by several hundred francs.Estimating The Intrinsic Value Of Givaudan SA (VTX:GIVN)
Oct 28Analysts Weigh Givaudan’s Outlook Amid CEO Transition and Adjusted Growth Forecasts
Analysts have slightly raised Givaudan's fair value estimate from CHF 3,996.53 to CHF 4,005.42. This change reflects updated expectations in light of moderated growth forecasts and cautious sentiment highlighted in recent price target revisions.Emerging Markets And Sustainable Ingredients Will Drive Future Expansion
Givaudan's analyst price target has been revised downward from CHF 4,081.95 to CHF 3,996.53, reflecting slightly lower revenue growth expectations and profit margin forecasts according to recent analyst updates. Analyst Commentary Recent analyst activity on Givaudan has resulted in a mix of revised targets and sentiment shifts that reflect both optimism around the company's strengths and caution regarding its outlook in the current market environment.Emerging Markets And Sustainable Ingredients Will Drive Future Expansion
Despite near-term pressures and a sector-wide derating, analysts remain positive on Givaudan's strong organic sales growth and long-term structural opportunities—particularly from regulatory-driven reformulation trends—resulting in only a marginal reduction of the consensus price target from CHF4127 to CHF4082. Analyst Commentary Givaudan is recognized for peer-leading organic sales growth, positioning it as a best-in-class flavor and fragrance company.Here's Why We Think Givaudan (VTX:GIVN) Is Well Worth Watching
Sep 22Emerging Markets And Sustainable Ingredients Will Drive Future Expansion
Analysts remain moderately optimistic on Givaudan, citing long-term benefits from regulatory-driven reformulation and market share gains tempered by near-term margin pressures and valuation concerns, resulting in an unchanged consensus price target of CHF4127. Analyst Commentary Bullish analysts expect Givaudan to benefit from industry-wide reformulation trends starting in 2026 as regulatory pressures phase out synthetic colors and ingredients, particularly in the U.S. Increases in price targets reflect confidence in Givaudan’s ability to capture incremental market share and drive organic growth amid evolving consumer preferences.Does Givaudan (VTX:GIVN) Have A Healthy Balance Sheet?
Aug 22Givaudan SA (VTX:GIVN) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Jul 24Givaudan SA's (VTX:GIVN) Price Is Out Of Tune With Earnings
Jul 17The Return Trends At Givaudan (VTX:GIVN) Look Promising
Jun 17Here's Why We Think Givaudan (VTX:GIVN) Might Deserve Your Attention Today
May 20
Bloomful Splash Launch Will Drive Future Success In Fragrance & Beauty
Strategic leadership changes and portfolio expansions may drive growth in revenue and earnings.Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Givaudan makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 25 | 7,472 | 1,071 | 1,236 | 551 |
| 30 Sep 25 | 7,506 | 1,083 | 1,251 | 556 |
| 30 Jun 25 | 7,539 | 1,094 | 1,266 | 560 |
| 31 Mar 25 | 7,476 | 1,092 | 1,244 | 563 |
| 31 Dec 24 | 7,412 | 1,090 | 1,222 | 565 |
| 30 Sep 24 | 7,265 | 1,061 | 1,184 | 551 |
| 30 Jun 24 | 7,117 | 1,032 | 1,146 | 537 |
| 31 Mar 24 | 7,016 | 963 | 1,126 | 528 |
| 31 Dec 23 | 6,915 | 893 | 1,105 | 519 |
| 30 Sep 23 | 6,958 | 879 | 1,106 | 518 |
| 30 Jun 23 | 7,000 | 865 | 1,106 | 516 |
| 31 Mar 23 | 7,059 | 861 | 1,109 | 519 |
| 31 Dec 22 | 7,117 | 856 | 1,112 | 522 |
| 30 Sep 22 | 7,040 | 818 | 1,130 | 538 |
| 30 Jun 22 | 6,963 | 780 | 1,148 | 553 |
| 31 Mar 22 | 6,824 | 801 | 1,157 | 558 |
| 31 Dec 21 | 6,684 | 821 | 1,165 | 562 |
| 30 Sep 21 | 6,579 | 816 | 1,145 | 557 |
| 30 Jun 21 | 6,474 | 811 | 1,124 | 552 |
| 31 Mar 21 | 6,398 | 777 | 1,098 | 544 |
| 31 Dec 20 | 6,322 | 743 | 1,072 | 536 |
| 30 Sep 20 | 6,326 | 739 | 1,063 | 533 |
| 30 Jun 20 | 6,330 | 735 | 1,054 | 530 |
| 31 Mar 20 | 6,267 | 719 | 1,038 | 529 |
| 31 Dec 19 | 6,203 | 702 | 1,021 | 528 |
| 30 Sep 19 | 6,075 | 687 | 1,000 | 520 |
| 30 Jun 19 | 5,947 | 672 | 978 | 512 |
| 31 Mar 19 | 5,737 | 668 | 956 | 495 |
| 31 Dec 18 | 5,527 | 663 | 934 | 477 |
| 30 Sep 18 | 5,385 | 685 | 914 | 460 |
| 30 Jun 18 | 5,242 | 707 | 894 | 442 |
| 31 Mar 18 | 5,147 | 714 | 877 | 433 |
| 31 Dec 17 | 5,051 | 720 | 859 | 424 |
| 30 Sep 17 | 4,932 | 690 | 849 | 417 |
| 30 Jun 17 | 4,812 | 660 | 839 | 409 |
| 31 Mar 17 | 4,738 | 652 | 839 | 405 |
| 31 Dec 16 | 4,663 | 644 | 839 | 400 |
| 30 Sep 16 | 4,605 | 648 | 829 | 390 |
| 30 Jun 16 | 4,546 | 651 | 819 | 380 |
| 31 Mar 16 | 4,471 | 638 | 806 | 373 |
| 31 Dec 15 | 4,396 | 625 | 793 | 366 |
| 30 Sep 15 | 4,397 | 613 | 800 | 378 |
| 30 Jun 15 | 4,397 | 600 | 807 | 390 |
Quality Earnings: GIVN has high quality earnings.
Growing Profit Margin: GIVN's current net profit margins (14.3%) are lower than last year (14.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GIVN's earnings have grown by 8.3% per year over the past 5 years.
Accelerating Growth: GIVN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GIVN had negative earnings growth (-1.7%) over the past year, making it difficult to compare to the Chemicals industry average (1.3%).
Return on Equity
High ROE: GIVN's Return on Equity (23.4%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/03 12:14 |
| End of Day Share Price | 2026/04/30 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Givaudan SA is covered by 37 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| James Knight | Barclays |